This review highlights mechanisms and therapies related to olfactory dysfunction in humans, indicating potential breakthroughs in treatment.
G protein–coupled receptors (GPCRs), the largest family of membrane proteins in mammals, are fundamental to olfactory signal transduction. By detecting odorant molecules and activating G protein–dependent and β‐arrestin–dependent signaling pathways, GPCRs regulate olfactory neuron depolarization, signal transmission, and adaptive modulation. This review comprehensively summarizes the molecular mechanisms of GPCRs in olfactory perception, signaling network regulation, and olfaction‐related disorders, including olfactory dysfunction, neurodegenerative diseases, and allergic inflammation. Furthermore, it highlights emerging therapeutic strategies such as biased ligands targeting GPCRs and stem cell–based interventions with clinical potential. Future investigations should prioritize elucidating the functions of orphan receptors and advancing precision therapeutic technologies to achieve breakthroughs in the diagnosis and treatment of olfaction‐related disorders.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: